To assess the effective ex vivo reversal of the effects of Rivaroxaban in healthy volunteers and patients

Trial Profile

To assess the effective ex vivo reversal of the effects of Rivaroxaban in healthy volunteers and patients

Completed
Phase of Trial: Phase I

Latest Information Update: 30 Nov 2016

At a glance

  • Drugs Rivaroxaban (Primary)
  • Indications Thromboembolism
  • Focus Pharmacokinetics
  • Most Recent Events

    • 30 Nov 2016 New trial record
    • 01 Nov 2016 Results published in the British Journal of Anaesthesia
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top